Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07NYF
|
|||
| Former ID |
DIB005893
|
|||
| Drug Name |
MLN-2201
|
|||
| Synonyms |
LDP-01; MLN-01; Anti-beta2-integrin MAb, LeukoSite
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Cerebrovascular ischaemia [ICD-11: 8B1Z; ICD-10: I67.8; ICD-9: 434.91] | Discontinued in Phase 1 | [1] | |
| Company |
LeukoSite Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010178) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010178) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.